Neural Bases of Post-stroke Emotion Perception Disorders
STROKEM
2 other identifiers
observational
80
1 country
1
Brief Summary
This monocentric physiological study will evaluate the neural bases of visual recognition of emotions in stroke patients vs. healthy controls using MRI (functional and structural connectivity) and EEG.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2022
CompletedFirst Posted
Study publicly available on registry
October 26, 2022
CompletedStudy Start
First participant enrolled
February 16, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedAugust 24, 2025
August 1, 2025
1.6 years
October 18, 2022
August 19, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BOLD signal when fear visual recognition
Compare correlations of cerebral functional activations (BOLD) by fMRI between groups when stimulus = fear
1 day
Secondary Outcomes (9)
BOLD signal when happiness visual recognition
1 day
Electrical connectivity (EEG) when fear visual recognition
1 day
Electrical connectivity (EEG) when fear happiness visual recognition
1 day
Electrical connectivity (EEG) when emotions auditory recognition
1 day
Relationship between behavioral performance and cerebral networks
1 day
- +4 more secondary outcomes
Study Arms (2)
Stroke
Stroke patients (ischemic or hemorrhagic) in the chronic phase (\> 6 months)
Healthy controls
Healthy adult controls
Eligibility Criteria
Patient group: 40 subjects Healthy control group: 40 subject
You may qualify if:
- Stroke group:
- Man or Woman
- Age 18-80y
- Unique stroke, ischemic or hemorrhagic
- at the chronic phase (\< 6 months)
- Written informed consent
- subject having a social insurance
- Subject who consent to complete all the study's experiments
- Healthy controls group:
- Man or Woman
- Age 18-80y
- No history of neurological or psychiatric disease.
You may not qualify if:
- Stroke group
- Subject who is unable to consent (due to dementia, severe aphasia, psychiatric disorder...)
- History of other neurologic disorders
- Significant le vel of depression or anxiety, assessed by the STAI and the BDI questionnaires
- Non corrected visual loss
- Subjects suffering from visual neglect (assessed by the Bells Test and a bisection test (20mm)
- contra-indications to MRI
- pregnant or breastfeeding woman
- Women of childbearing age without effective contraception
- Healthy controls group
- Subject who is unable to consent (due to dementia, severe aphasia, psychiatric disorder...)
- History of neurologic disorders
- Significant level of depression or anxiety, assessed by the STAI and the BDI questionnaires
- Non-corrected visual loss
- contra-indications to MRI
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Swynghedauw
Lille, 59037, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Etienne Allart, MD
University Hospital, Lille
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2022
First Posted
October 26, 2022
Study Start
February 16, 2024
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
August 24, 2025
Record last verified: 2025-08